← Back to Search

shared care for Attention Deficit Hyperactivity Disorder (ADHD) (shared care Trial)

Waitlist Available
Led By Rachel Zuckerbrot, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 6-17
Suspected diagnosis of ADHD, inattentive type, hyperactive type, combined type, NOS
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights

shared care Trial Summary

Due to the shortage of child psychiatrists and the high prevalence of child mental health disorder, pediatricians and other pediatric primary care providers often assume responsibility for the management of various psychiatric disorders, including ADHD, Attention Deficit Hyperactivity Disorder. However, pediatricians have not been well-trained during residency to deal with the complexities of ADHD management. In addition, the system of care under which pediatricians practice do not afford the time availability that is required to properly manage a child with ADHD. On the other hand, if a pediatrician wishes to refer a patient to a child mental health specialist, many obstacles, including but not limited to stigma, insurance issues, and long waiting lists, often interfere with the patient actually receiving services for his/her ADHD. This research project seeks to examine an innovative model of care in which a child psychologist is located on the premises of a pediatric office and is available to share the care of patients with the pediatrician in order to address ADHD. We hypothesize that parents as well as pediatricians will be more satisfied with this model of care and that patients will ultimately have better outcomes. The beginning of our pilot has shown under-identification to be a barrier to care as well, and thus we propose to implement a quality improvement initiative to screen children for psychosocial issues as well. As we have had trouble with recruitment and unfortunately have had more children randomized to TAU than shared care, we propose in December 2007 a phase 2 of our study where all subjects, instead of randomization, are entered into shared care.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

shared care Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

shared care Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
A higher proportion of patients treated by the pediatric providers and psychologists than those in usual care receive doses of medication that are consistent with AAP (American Academy of Pediatrics) recommendations
Secondary outcome measures
2. Patients whose providers are offered to receive the aid of the co-located psychologists will be more likely to be co-managed by the pediatrician than referred out to the community.
Co-located services will increase the number of ADHD patients accessing specialized mental health treatment services
Parents will be more satisfied with care in the shared care model than in usual care

shared care Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: shared careExperimental Treatment1 Intervention
A psychologist co-located in the pediatric primary care clinic shared care with the subject's pediatrician. The psychologist offered regular appointments and psychoeducation. On an individual basis, parent management training, behavioral management training, individual psychotherapy, educational intervention assistance, teacher communication, and medication education were provided as needed.
Group II: TAUActive Control1 Intervention
Treatment as usual. These subjects and their providers were told to pursue treatment services as they normally would do.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,388 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
106 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,688,967 Total Patients Enrolled
94 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
19,905 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
New York State Psychiatric InstituteOTHER
475 Previous Clinical Trials
153,767 Total Patients Enrolled
11 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
610 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025